Related Experiment Video

Updated: Mar 3, 2026

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.7K

Expression levels of microRNA‑455 and its potential functions by targeting IGF‑1R in melanoma

Hui Wang1, Liang Yu2, Xiujuan Shan1

  • 1Department of Dermatology, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.

Molecular Medicine Reports
|April 26, 2017
PubMed

Insights

MicroRNA-455 (miR-455) is downregulated in melanoma, acting as a tumor suppressor. Restoring miR-455 levels inhibits melanoma cell proliferation and invasion by targeting the insulin-like growth factor 1 receptor (IGF-1R).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melanoma is a highly fatal skin cancer.
  • MicroRNAs (miRNAs) play crucial roles in cancer, acting as tumor suppressors or oncogenes.
  • Modulating miRNA activity presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To investigate the expression levels and function of miR-455 in melanoma.
  • To identify the molecular targets of miR-455 in melanoma.
  • To evaluate the therapeutic potential of restoring miR-455 in melanoma.

Main Methods:

  • Expression analysis of miR-455 in melanoma tissues and cell lines.
  • Functional assays (cell proliferation, invasion) upon miR-455 modulation.
  • Bioinformatic analysis to predict miR-455 targets.
  • Luciferase reporter assays, RT-qPCR, and Western blot to validate miR-455 targeting of IGF-1R.

Main Results:

  • miR-455 expression was significantly downregulated in melanoma compared to normal tissues.
  • Overexpression of miR-455 reduced melanoma cell proliferation and invasion.
  • Insulin-like growth factor 1 receptor (IGF-1R) was confirmed as a direct target of miR-455.
  • IGF-1R knockdown mimicked the effects of miR-455 overexpression.

Conclusions:

  • miR-455 acts as a tumor suppressor in melanoma by inhibiting proliferation and invasion.
  • The tumor-suppressive function of miR-455 is mediated through direct targeting of IGF-1R.
  • Restoration of miR-455 represents a potential therapeutic avenue for melanoma treatment.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K